Next Article in Journal
Progress and Hurdles of Therapeutic Nanosystems against Cancer
Next Article in Special Issue
Safety and Pharmacokinetic Assessment of Oral Proglumide in Those with Hepatic Impairment
Previous Article in Journal
Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells
Previous Article in Special Issue
The Influence of Fed State Lipolysis Inhibition on the Intraluminal Behaviour and Absorption of Fenofibrate from a Lipid-Based Formulation
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(2), 387; https://doi.org/10.3390/pharmaceutics14020387
Action Date Notes Link
article xml file uploaded 10 February 2022 11:08 CET Original file -
article xml uploaded. 10 February 2022 11:08 CET Update -
article pdf uploaded. 10 February 2022 11:08 CET Version of Record https://www.mdpi.com/1999-4923/14/2/387/pdf-vor
article supplementary file uploaded. 10 February 2022 11:08 CET - https://www.mdpi.com/1999-4923/14/2/387#supplementary
article html file updated 10 February 2022 11:28 CET Original file -
article xml file uploaded 11 February 2022 02:11 CET Update -
article xml uploaded. 11 February 2022 02:11 CET Update -
article pdf uploaded. 11 February 2022 02:11 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/387/pdf-vor
article html file updated 11 February 2022 02:12 CET Update -
article xml file uploaded 24 February 2022 03:29 CET Update -
article xml uploaded. 24 February 2022 03:29 CET Update https://www.mdpi.com/1999-4923/14/2/387/xml
article pdf uploaded. 24 February 2022 03:29 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/387/pdf
article html file updated 24 February 2022 03:30 CET Update -
article html file updated 31 July 2022 13:49 CEST Update https://www.mdpi.com/1999-4923/14/2/387/html
Back to TopTop